Beta Bionics Inc.
BBNX | NASDAQ
$16.55
-$0.20 (-1.19%)
Nov 2, 2026, 10:26 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
PE Ratio | -16.83 | -18.46 | -22.94 | -15.65 |
PEG Ratio | -0.41 | -0.76 | 0.72 | n/a |
PS Ratio | 12.32 | 15.55 | 84.43 | 5.66K |
PB Ratio | 4.29 | 13.32 | 17.28 | -5.96 |
P/FCF Ratio | -21.97 | -19.60 | -30.83 | -16.61 |
P/OCF Ratio | -24.25 | -20.98 | -31.21 | -16.82 |
OCF/S Ratio | -50.80 | -74.12 | -270.49 | -33.64K |
Debt / Equity Ratio | 0.03 | 0.10 | 0.07 | -0.02 |
Quick Ratio | 7.96 | 5.66 | 9.65 | 3.21 |
Current Ratio | 8.66 | 6.29 | 9.77 | 3.21 |
Asset Turnover | 0.30 | 0.44 | 0.11 | 0.01 |
Interest Coverage | n/a | n/a | n/a | -4.7K |
Return on Equity | -25.45% | -72.03% | -75.24% | 38.08% |
Return on Assets | -22.27% | -36.59% | -40.08% | -182.26% |
Return on Invested Capital | -23.91% | -34.80% | -35.62% | -238.31% |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | 55.40% | 55.11% | 52.59% | 100% |
Net Profit Margin | -73.02% | -84.08% | -367.64% | -36.17K% |
Pretax Profit Margin | -73.02% | -84.08% | -367.64% | -36.17K% |
Operating Profit Margin | -71.50% | -69.48% | -298.87% | -36.78K% |
FCF Margin | -56.08% | -79.34% | -273.84% | -34.07K% |
EBITDA Margin | -70.15% | -80.57% | -350.21% | -35K% |
Add to Watchlist
Select watchlists to add or remove BBNX